Neurology
Opinion
FDA approval of powerful opioid tinged with irony
The agency’s approval of Dsuvia comes at a time when the need is great for nonaddictive agents for pain control.
Latest News
Drug overdose deaths down since late 2017
Longer-term trend, however, shows an increase of 2.7% during the 12 months ending in March 2018, compared with March 2017.
News
Anti-inflammatory Drug Could Help Prevent MS Brain Tissue Loss
Study reveals a common asthma and stroke treatment may help prevent brain shrinkage in MS patients.
Conference Coverage
MS cognitive decline buffered by early high vitamin D levels
BERLIN – Smokers took a “clinically significant” cognitive hit, however.
Conference Coverage
Relapsing-remitting MS best treated within 6 months of onset
BERLIN – Disease-modifying treatment for relapsing-remitting multiple sclerosis decreased the risk of disability progression at 12 months by 28...
News
Policy responses to opioid epidemic may have benefits, harms
Drug rescheduling was associated with a 45.6% increase in heroin-related deaths over 5 years in the model.
News
Declining lung function linked to heart failure, stroke
Cardiologists and pulmonologists should collaborate to better identify the relationship between lung function decline and early CV disease...
Pilot Program
Cognitive Behavioral Therapy for Veterans With Tinnitus
Cognitive behavioral therapy encourages acquisition, practice, and use of a range of specific coping strategies to enhance perceptions of self-...
News
Opioids, other causes linked to shorter lifespans, rising midlife mortality
Life expectancy has dipped, and death rate for the 25-64 year age range is rising among multiple ethnic groups.
News
New Evidence May Explain How Viruses Act in Alzheimer Disease
Discovery reveals “strong evidence” that links herpes viruses to a role in Alzheimer disease biology.